Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Identify scenarios where a sinking fund is more appropriate than a traditional emergency fund, such as planned repairs or purchases, to keep finances organized.
20,807 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Two big drivers could push Truist stock higher in 2026: cheaper funding and faster loan growth. This article breaks d...
Turning your home into a steady income stream is closer than you think. This guide shows how to reach about $1,200 a ...
A Switzerland-registered firm launches the $BANK token on Solana, offering on-chain exposure to a professionally mana...
Lucid delivered higher volumes and nudged toward improving efficiency, signaling a potential turn in its long EV jour...
Not all tech stocks pay dividends, but a small group do. Here are two reliable picks that blend growth with income, p...
Markets showed modest gains as the Fed meeting kicked off, with tech and travel shares helping lift indexes. This gui...
Long-term wealth isn’t built on quick trades. It comes from steady income and durable growth. Here are two monster di...
When yields rise, even patient investors can feel the pressure. This guide explains what rising treasury yields spook...
Meta’s latest quarter hints at more than just headline growth. This article explains why some investors excited about...
After an 11% drop, investors wonder if CoreWeave stock can rebound. This article weighs the bull and bear cases, what...
A hypothetical SpaceX IPO could ignite a wave for artificial intelligence (ai) stocks. This article identifies two le...